Palomino Laboratories Inc. (PALX)

Palomino Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-	-	-0.17	-1.49
Net Debt / Equity Ratio	-1.00	-1.00	7.18	64.70
Quick Ratio	24.14	24.14	20.94	26.91
Current Ratio	25.07	25.07	21.48	26.91
Return on Equity (ROE)	-78.30%	-78.30%	-	-
Return on Assets (ROA)	-39.41%	-39.41%	-2.76%	-
Return on Capital Employed (ROCE)	-33.40%	-33.40%	-4.60%	-12.80%
Buyback Yield / Dilution	-340.48%	-340.48%	-147.88%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 16, 2026

Data Sources Report a data error